Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
AZN
AZN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AZN News
Joshua Jackson Partners with AstraZeneca to Promote Cancer Screening
10h ago
Newsfilter
AstraZeneca's Koselugo Approved in Canada
1d ago
NASDAQ.COM
ENHERTU Shows 53% Reduction in Recurrence Risk in Breast Cancer Trial
1d ago
Newsfilter
Daiichi Sankyo and AstraZeneca's ENHERTU Application Receives Priority Review
1d ago
NASDAQ.COM
ENHERTU Shows 53% Reduction in Breast Cancer Recurrence Risk in Phase 3 Trial
1d ago
Newsfilter
Xencor Lowers Outlook After Royalty Dispute
5d ago
seekingalpha
Xencor Lowers Revenue Outlook for Ultomiris Royalties
5d ago
Benzinga
Salesforce's Strategic Shift in the Age of AI
Mar 03 2026
Yahoo Finance
Global ETF Surges as Investors Abandon U.S. Stocks
Mar 02 2026
Marketbeat
AstraZeneca Prices $2 Billion Bond Offering
Feb 26 2026
NASDAQ.COM
Avacta Releases Favorable Preclinical Data for AVA6103 Compared to Enhertu
Feb 24 2026
Yahoo Finance
PVAL Stock Price Analysis and ETF Dynamics
Feb 23 2026
NASDAQ.COM
CALQUENCE and Venetoclax Approved by FDA for CLL Treatment
Feb 20 2026
Newsfilter
Record Surge in Drug Licensing Deals from China
Feb 19 2026
seekingalpha
ENHERTU Shows Promising Results in Breast Cancer Treatment
Feb 19 2026
Newsfilter
AstraZeneca and Bristol Myers Squibb Collaborate with Evinova for AI Drug Development
Feb 18 2026
seekingalpha
Show More News
